What does GEASSOCIEERDE APOTHEEK DE RIDDER do?

GEASSOCIEERDE APOTHEEK DE RIDDER is a pharmacy in Ninove. Cooperative, started on 5 December 2016, 1 establishment.

What is the address of GEASSOCIEERDE APOTHEEK DE RIDDER?

The registered office of GEASSOCIEERDE APOTHEEK DE RIDDER is located at Beverstraat 6, 9400 Ninove.

Is GEASSOCIEERDE APOTHEEK DE RIDDER still active?

Yes. According to the CBE (30 September 2026) GEASSOCIEERDE APOTHEEK DE RIDDER is active, legal situation “Normale toestand”, started on 5 December 2016.

Is GEASSOCIEERDE APOTHEEK DE RIDDER registered on Peppol?

Yes, GEASSOCIEERDE APOTHEEK DE RIDDER is registered on the Peppol network with ID 0208:0666931715.

What is the enterprise number of GEASSOCIEERDE APOTHEEK DE RIDDER?

The enterprise number of GEASSOCIEERDE APOTHEEK DE RIDDER is BE0666931715.

When was GEASSOCIEERDE APOTHEEK DE RIDDER founded?

GEASSOCIEERDE APOTHEEK DE RIDDER was founded on 5 December 2016.

Who are the directors of GEASSOCIEERDE APOTHEEK DE RIDDER?

According to the 2025 annual accounts, the directors of GEASSOCIEERDE APOTHEEK DE RIDDER are: Jan Mannaerts, S & S Invest & Consultancy BV.

Is GEASSOCIEERDE APOTHEEK DE RIDDER a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 5 December 2016; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did GEASSOCIEERDE APOTHEEK DE RIDDER make in 2025?

GEASSOCIEERDE APOTHEEK DE RIDDER recorded a loss after taxes of € 17,757 in financial year 2025.

What is the revenue of GEASSOCIEERDE APOTHEEK DE RIDDER?

As a small company, GEASSOCIEERDE APOTHEEK DE RIDDER is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 66,026.

How much does an employee at GEASSOCIEERDE APOTHEEK DE RIDDER earn?

The average wage cost per full-time employee at GEASSOCIEERDE APOTHEEK DE RIDDER was € 45,500 in 2025: staff costs of € 45,531 for 1 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does GEASSOCIEERDE APOTHEEK DE RIDDER have?

According to the 2025 annual accounts, GEASSOCIEERDE APOTHEEK DE RIDDER has 1 full-time equivalents (FTE).

Does GEASSOCIEERDE APOTHEEK DE RIDDER have a website?

Yes, GEASSOCIEERDE APOTHEEK DE RIDDER has a website at apotheeksaraderidder.be.

GEASSOCIEERDE APOTHEEK DE RIDDER (Cooperative) - Ninove

Dossier GEASSOCIEERDE APOTHEEK DE RIDDER, printed on 30 September 2026 from databakkes.be/en/0666931715/geassocieerde-apotheek-de-ridder. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Negative equity NBB

More debt than assets in 4 of the last 4 fiscal years.
Two loss years in a row NBB

Negative result in 2024 and 2025.
Tight liquidity NBB

Cash and receivables cover 20 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

GEASSOCIEERDE APOTHEEK DE RIDDER from Ninove, company number BE0666931715, closed financial year 2025 with a result of € -17,757 after tax. For that financial year GEASSOCIEERDE APOTHEEK DE RIDDER recorded a gross margin of € 66,026 and equity of € -28,792. Compared with financial year 2024, the result moved from € -6,731 to € -17,757. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 27, 2026.

What it is worth Caution

€ -28,792

▼ € 17,757 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -17,757

▼ 164 % more loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 4,248

▲ 78% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -68,792.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 45,531

▲ 3% vs 2024

€ 45,500 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 1,523

▲ 10% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 1 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 77,589

▼ 41% vs 2024

€ 48,695 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.

Owed to suppliers

€ 65,524

▲ 79% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 6,167

▲ 9% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 42,928 Gross margin 2022: € 42,928 First fiscal year in the series	€ 65,153 Gross margin 2023: € 65,153 ▲ 52% vs 2022 (€ 42,928) Favourable step	€ 71,191 Gross margin 2024: € 71,191 ▲ 9% vs 2023 (€ 65,153) Favourable step	€ 66,026 Gross margin 2025: € 66,026 ▼ 7% vs 2024 (€ 71,191) Unfavourable step	▼ 7%
Profit after taxes	€ 3,923 Profit after taxes 2022: € 3,923 First fiscal year in the series	€ 12,681 Profit after taxes 2023: € 12,681 ▲ 223% vs 2022 (€ 3,923) Favourable step	€ -6,731 Profit after taxes 2024: € -6,731 ▼ € 19,411 vs 2023 (€ 12,681) Unfavourable step	€ -17,757 Profit after taxes 2025: € -17,757 ▼ € 11,026 vs 2024 (€ -6,731) Unfavourable step	▼ € 11,026
Equity	€ -16,985 Equity 2022: € -16,985 First fiscal year in the series	€ -4,304 Equity 2023: € -4,304 ▲ € 12,681 vs 2022 (€ -16,985) Favourable step	€ -11,035 Equity 2024: € -11,035 ▼ € 6,731 vs 2023 (€ -4,304) Unfavourable step	€ -28,792 Equity 2025: € -28,792 ▼ € 17,757 vs 2024 (€ -11,035) Unfavourable step	▼ € 17,757
Total debts	€ 323,555 Total debts 2022: € 323,555 First fiscal year in the series	€ 282,436 Total debts 2023: € 282,436 ▼ 13% vs 2022 (€ 323,555) Favourable step	€ 271,838 Total debts 2024: € 271,838 ▼ 4% vs 2023 (€ 282,436) Favourable step	€ 259,816 Total debts 2025: € 259,816 ▼ 4% vs 2024 (€ 271,838) Favourable step	▼ 4%
Cash	€ 4,065 Cash 2022: € 4,065 First fiscal year in the series	€ 2,553 Cash 2023: € 2,553 ▼ 37% vs 2022 (€ 4,065) Unfavourable step	€ 2,390 Cash 2024: € 2,390 ▼ 6% vs 2023 (€ 2,553) Unfavourable step	€ 4,248 Cash 2025: € 4,248 ▲ 78% vs 2024 (€ 2,390) Favourable step	▲ 78%
Retained profit	€ -56,985 Retained profit 2022: € -56,985 First fiscal year in the series	€ -44,304 Retained profit 2023: € -44,304 ▲ € 12,681 vs 2022 (€ -56,985) Favourable step	€ -51,035 Retained profit 2024: € -51,035 ▼ € 6,731 vs 2023 (€ -44,304) Unfavourable step	€ -68,792 Retained profit 2025: € -68,792 ▼ € 17,757 vs 2024 (€ -51,035) Unfavourable step	▼ € 17,757
Bank debt	€ 143,645 Bank debt 2022: € 143,645 First fiscal year in the series	€ 140,457 Bank debt 2023: € 140,457 ▼ 2% vs 2022 (€ 143,645) Favourable step	€ 132,316 Bank debt 2024: € 132,316 ▼ 6% vs 2023 (€ 140,457) Favourable step	€ 77,589 Bank debt 2025: € 77,589 ▼ 41% vs 2024 (€ 132,316) Favourable step	▼ 41%
Balance sheet total	€ 306,570 Balance sheet total 2022: € 306,570 First fiscal year in the series	€ 278,132 Balance sheet total 2023: € 278,132 ▼ 9% vs 2022 (€ 306,570) Unchanged	€ 260,803 Balance sheet total 2024: € 260,803 ▼ 6% vs 2023 (€ 278,132) Unchanged	€ 231,024 Balance sheet total 2025: € 231,024 ▼ 11% vs 2024 (€ 260,803) Unchanged	▼ 11%
Employees (FTE)	-	0.3 Employees (FTE) 2023: 0.3 First fiscal year in the series	1 Employees (FTE) 2024: 1 ▲ 0.7 vs 2023 (0.3) Unchanged	1 Employees (FTE) 2025: 1 Unchanged (1) Unchanged

Key figures of GEASSOCIEERDE APOTHEEK DE RIDDER, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to GEASSOCIEERDE APOTHEEK DE RIDDER?

What happened at GEASSOCIEERDE APOTHEEK DE RIDDER in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2029 Jan Mannaerts stepped down as director. NBB
2029 S & S Invest & Consultancy BV stepped down as director. NBB
Jun 27, 2026 New annual accounts for financial year 2025: loss of € 17,757. Source: NBB ↗
2023 Jan Mannaerts became a director. NBB
2023 S & S Invest & Consultancy BV became a director. NBB
Dec 5, 2016 New establishment in Ninove. KBO
Dec 5, 2016 Start of the company according to the CBE. KBO

In short

From € 3,923 profit in 2022 to € 17,757 loss in 2025.

Paid € 938 in corporate taxes since 2022.

Best year ever: 2023, with € 12,681 profit.

On average € 66,000 of value added per employee in 2025.

Original PDFs at the National Bank ↗

A new publication or filing at GEASSOCIEERDE APOTHEEK DE RIDDER? We notify you, reason included.

Follow GEASSOCIEERDE APOTHEEK DE RIDDER

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

AFS 37.5%

The stake of AFS comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

GEASSOCIEERDE APOTHEEK DE RIDDER

The shares are held by AFS (37.5%).

See the full network in the app

Directors

According to the 2025 annual accounts

Jan Mannaerts

Director

since 2023 · until 2029

S & S Invest & Consultancy BV

Director · represented by Sara De Ridder

since 2023 · until 2029

Shareholders

AFS

37.5%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Beverstraat 6

9400 Ninove

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

S&S INVEST & CONSULTANCY same network

€ 24,833 gross margin · 2025

HS Renovations

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS apotheeksaraderidder.be

Technologies

ApacheGoogle FontsPHPVarnish

Hosting & Email

Email provider

Self-hosted

Hosting

ONECOM, DK

Website info

HTTPS Ja

Indexable pages 1

Features

Security

✓ HTTPS

✗ SPF

✗ DMARC

Network

✓ IPv6

Details

Company number: 0666.931.715
VAT number: BE 0666.931.715
Registered office: Beverstraat 6, 9400 Ninove
Names & denominations: GEASSOCIEERDE APOTHEEK DE RIDDER · G.A. DE RIDDER
Enterprise type: Rechtspersoon
Legal form: Cooperative company
Legal situation: Normale toestand
Start date: 5 December 2016
Peppol: Active · Active since 16 Dec 2024
Contact: apotheeksaraderidder.be
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗